Asia Pacific Pharmaceutical Manufacturing Industry

Asia Pacific pharmaceutical manufacturing industry market will grow by 11.3% annually with a total addressable market cap of $57.26 billion over 2023-2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing … Read more

Asia Pacific pharmaceutical manufacturing industry will grow by 14.8% annually with a total addressable market cap of $1,034.6 billion over 2021-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.Highlighted with 33 tables and 63 … Read more